Opportunities
Search

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: IJsselgemeenten | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Région Bourgogne Franche Comté | Notice type: cn-standard | Procedure: oth-single | Contract: services | Deadline: 2026-09-02

Buyer: Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Centrale municipale d'achat et d'impression de la Ville de Genève | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: ISOB Bureau | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: Gemeente Rheden | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Stichting Primair Onderwijs Viadere | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: MĚSTO ČERVENÝ KOSTELEC | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Česká republika - Ministerstvo obrany | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2026-09-02

Buyer: ISOB Bureau | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: Gemeente Helmond | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Nederlandse Organisatie voor Wetenschappelijk Onderzoek | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Gemeente Meierijstad | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: gemeente Nissewaard | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: SITREVA | Notice type: cn-standard | Contract: services | Deadline: 2026-09-02

Buyer: Transports publics de la région lausannoise sa | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.Distinctive Features:• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. This mechanism promotes new ideas that are in the early stages of development and have the potential to yield impactful data and new avenues of investigation. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This FY26 LCRP IDA mechanism has a New Investigator category that is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data in one or more of the following research areas: Analysis of clinically annotated datasets; analysis of -omics data; artificial intelligence and machine learning; bioinformatics; computational biology; digital pathology; epidemiology; and medical imaging. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: ·        Early-Career Investigator: Serves as the principal investigator. Includes investigators possessing a doctoral degree or equivalent with fewer than three years of postdoctoral research experience at the application submission deadline, excluding clinical residency or clinical fellowship training. ·        Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship. ·        Researcher Development Plan: Applications must include a researcher development plan articulating an individualized strategy for acquiring necessary skills, competence, and expertise to complete the project and foster the Principal Investigator’s (PI’s) career development